The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes based on multigene profiling in metastatic breast cancer patients.
 
Reva Kakkar Basho
Employment - DaVita (I)
Stock and Other Ownership Interests - DaVita (I)
 
Debora De Melo Gagliato
No Relationships to Disclose
 
Naoto T. Ueno
No Relationships to Disclose
 
Ricardo H. Alvarez
Consulting or Advisory Role - Eisai; Novartis
 
Chetna Wathoo
No Relationships to Disclose
 
Huiqin Chen
No Relationships to Disclose
 
Caimiao Wei
No Relationships to Disclose
 
Aysegul A. Sahin
No Relationships to Disclose
 
Sinchita Roy-Chowdhuri
No Relationships to Disclose
 
Stacy L. Moulder
No Relationships to Disclose
 
Mariana Chavez-Mac Gregor
Consulting or Advisory Role - Genomic Health; Novartis; Roche; Roche
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Genomic Health; Novartis
 
Jennifer Keating Litton
Research Funding - Biomarin (Inst); Bristol-Myers Squibb (Inst); MedImmune (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Biomarin; Novartis
 
Vicente Valero
No Relationships to Disclose
 
Rajyalakshmi Luthra
No Relationships to Disclose
 
Kenna Rael Shaw
No Relationships to Disclose
 
John Mendelsohn
Leadership - Merrimack
Consulting or Advisory Role - Capital Royalty
Patents, Royalties, Other Intellectual Property - ImClone Systems
 
Gordon B. Mills
Stock and Other Ownership Interests - Catena; PTV Sciences; Spindletop Ventures
Honoraria - AstraZeneca; Illumina; Nuevolution; Symphony Evolution
Consulting or Advisory Role - AstraZeneca; Blend Therapeutics; Critical Outcome Technologies; HanAl Bio Korea; Illumina; Nuevolution; Pfizer; Provista Diagnostics; Roche Pharma AG; SignalChem; Symphony Evolution; Tau Therapeutics
Research Funding - Adelson Medical Research Foundation; AstraZeneca; Critical Outcome Technologies; GlaxoSmithKline; Illumina
Patents, Royalties, Other Intellectual Property - Cytovia, Inc; Millennium
Travel, Accommodations, Expenses - AstraZeneca; Illumina; Nuevolution; Symphony Evolution
 
Debu Tripathy
Consulting or Advisory Role - Eisai; OncoPlex Diagnostics
Research Funding - Genentech/Roche; Novartis; Pfizer
Travel, Accommodations, Expenses - Eisai
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche; Sysmex
Consulting or Advisory Role - Genentech; Novartis; Roche
Research Funding - AstraZeneca; Bayer; Calithera Biosciences; Debiopharm Group; Genentech; Novartis; Taiho Pharmaceutical